%0 Journal Article
%T Guidance on COVID-19 Vaccination in Hidradenitis Suppurativa Patients: A Modified Delphi Consensus of Experts.
%A Rick JW
%A De DR
%A Shih T
%A Alavi A
%A Kirby JS
%A Naik HB
%A Frew JW
%A Sayed CJ
%A Hsiao JL
%A Shi VY
%A Rick JW
%A De DR
%A Shih T
%A Alavi A
%A Kirby JS
%A Naik HB
%A Frew JW
%A Sayed CJ
%A Hsiao JL
%A Shi VY
%J Skin Appendage Disord
%V 8
%N 4
%D Jul 2022
%M 35979524
暂无%R 10.1159/000521268
%X <B>UNASSIGNED: </B>Hidradenitis suppurativa (HS) patients may be at increased risk of COVID-19 infection and complications from their medications and comorbidities. There is a lack of expert consensus on recommendations for the COVID-19 vaccine for HS patients. Herein, we aim to provide expert-driven consensus recommendations regarding COVID-19 vaccinations in HS patients.<BR><B>UNASSIGNED: </B>A modified Delphi consensus survey developed by a core committee of 7 dermatologist HS experts consisting of 4 demographic questions and 12 practice statements was distributed to the US HS Foundation-sponsored provider listserv. Participants were attending physician HS experts. Survey results were to be reviewed by the core group and revised and resubmitted until consensus (≥70% agreement) was achieved.<BR><B>UNASSIGNED: </B>Among the 33 survey participants, there were 30 (87%) dermatologists, 1 general surgeon, 1 plastic surgeon, and 1 rheumatologist. Consensus for all 12 statements on vaccine counseling and HS treatment counseling was achieved after the first round.<BR><B>UNASSIGNED: </B>For now, this consensus can serve as a resource for clinicians discussing COVID-19 vaccination with their HS patients. These recommendations will need to be updated as new evidence on COVID-19 emerges.